Pressurized Metered Dose Inhaler Market

A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.
Pressurized Metered Dose Inhaler Market contains market size and forecasts of Pressurized Metered Dose Inhaler in global, including the following market information:
Global Pressurized Metered Dose Inhaler Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pressurized Metered Dose Inhaler Market Sales, 2017-2022, 2023-2028, (M Units)
Global top five Pressurized Metered Dose Inhaler companies in 2021 (%)
The global Pressurized Metered Dose Inhaler market was valued at 6205.4 million in 2021 and is projected to reach US$ 7815 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Manual Pressurized Metered Dose Inhaler Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pressurized Metered Dose Inhaler include GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, Teva, Merck & Co. Inc, Boehringer Ingelheim, Mylan and Arkon, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pressurized Metered Dose Inhaler manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pressurized Metered Dose Inhaler Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Pressurized Metered Dose Inhaler Market Segment Percentages, by Type, 2021 (%)
Manual Pressurized Metered Dose Inhaler
Smart Pressurized Metered Dose Inhaler
Global Pressurized Metered Dose Inhaler Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Pressurized Metered Dose Inhaler Market Segment Percentages, by Application, 2021 (%)
Asthma
COPD
Others
Global Pressurized Metered Dose Inhaler Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Pressurized Metered Dose Inhaler Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pressurized Metered Dose Inhaler revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pressurized Metered Dose Inhaler revenues share in global market, 2021 (%)
Key companies Pressurized Metered Dose Inhaler sales in global market, 2017-2022 (Estimated), (M Units)
Key companies Pressurized Metered Dose Inhaler sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Chiesi Farmaceutici S.p.A
AstraZeneca
Teva
Merck & Co. Inc
Boehringer Ingelheim
Mylan
Arkon